GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (FRA:1XT) » Definitions » Other Cash Receipts from Operating Activities

Xintela AB (FRA:1XT) Other Cash Receipts from Operating Activities


View and export this data going back to 2018. Start your Free Trial

What is Xintela AB Other Cash Receipts from Operating Activities?

Other Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Xintela AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xintela AB (FRA:1XT) » Definitions » Other Cash Receipts from Operating Activities
Traded in Other Exchanges
Address
Medicon Village, Lund, SWE, 22381
Xintela AB is a biomedical company that develops stem cell-based treatments with a focus on osteoarthritis and hard-to-heal leg wounds as well as, through the wholly-owned subsidiary Targinta, targeted antibody-based treatments for aggressive cancers such as triple-negative breast cancer and the brain tumor glioblastoma.